01
OUR MOST APPRECIATED WORK
TWO MASTER
Oncology reports
360 Degree Insights on Drug Development
Covers 2350 Active Cancer Drug Developers.
Analysis on 4300+ Active Cancer Targeting Molecules in Development.
Complete 1500+ Deals & Partnering Details.
Special coverage on CAR-T/NK Cell Therapies, Vaccines, ADCs, Monoclonal / Bispecific Antibodies, Oncolytic Viruses and Small molecule Kinase Inhibitors.
Oncology Clinical Drug Developers - 2022
World's Largest Insights on Active Global 1150 Clinical Stage Oncology Drug Developers. ----------------------------------------- Includes Insights on Companies | Technologies Pipeline | Targets | Deals | Funding
Buy NowReport provides an extensive coverage on Oncology Drug Development and includes World’s Largest Number of Active Clinical Stage Oncology Drug Developers. (1150 Companies Profiles)
1200 Pages provides, in-depth Analysis on
- GLOBAL 1150 CLINICAL STAGE ONCOLOGY DRUG DEVELOPERS.
- 3500+ CANCER TARGETING MOLECULES IN DEVELOPMENT.
- EMERGING CANCER DRUG TARGETS & PROPERITORY TECHNOLOGIES.
- ONCOLOGY FOCUSED DEALS & PARTNERING ACTIVITIES.
- INDIVIDUAL COMPANY FUNDING STATUS
Report opens an immense opportunities to New Business Development.
Explore More
Single Source Solution to Reach-out and connect World’s Largest Number of Active Early Stage Oncology Drug Developers. (1200 Companies).
865 Pages Report contains in-depth Analysis on
- 1200 ACTIVE COMPANIES PROFILE
- 1400+ CANCER TARGETING MOLECULES IN DEVELOPMENT.
- EMERGING CANCER DRUG TARGETS & PROPERITORY TECHNOLOGIES.
- ONCOLOGY FOCUSED DEALS & PARTNERING ACTIVITIES.
- INDIVIDUAL COMPANY FUNDING STATUS, and much more.
Report opens an immense opportunities to New Business Development.
Explore More
Oncology Preclinical Drug Intelligence - 2022
World's Largest Insights on Active Global 1200 PreClinical Stage Oncology Drug Developers ----------------------------------------- Includes Insights on Companies | Technologies Pipeline | Targets | Deals | Funding
Buy Now